Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

WHARNIS (NEW FORMULA) CAPSULES - PPB Drug Approval Details

Approvals/PPB/WHARNIS (NEW FORMULA) CAPSULES

Approved

STANDARD

WHARNIS (NEW FORMULA) CAPSULES

EUROPHARM LAB CO LTD🇰🇪 Pharmacy and Poisons Board

Approval Date: Jun 21, 2024
Approval ID: 1b4fa0e46da5e994
Company: EUROPHARM LAB CO LTD
Type: Standard

Approval Details

Approval Id: 1b4fa0e46da5e994
Product Name: WHARNIS (NEW FORMULA) CAPSULES
Drug Hk Name: WHARNIS (NEW FORMULA) CAPSULES
Registration Code: HK-62440
Company Name: EUROPHARM LAB CO LTD
Company Detail Path: /organization/europharm-laboratoires-company-limited
Registration Category: Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement: Prescription only Medicines
Registration Date: 2013-11-29
Company Address: 12-14 DAI WANG ST, TAI PO IND EST, TAI PO, NEW TERRITORIES

Active Ingredients

Approved

Quick Info

Agency

PPB

Country

🇰🇪

Approval Date

Jun 21, 2024

Approval ID

1b4fa0e46da5e994

Type

Standard

Back to PPB Approvals